ACETALDEHYDE-SERUM PROTEIN ADDUCTS INHIBIT INTERLEUKIN-2 SECRETION IN CONCANAVALIN A-STIMULATED MURINE SPLENOCYTES - A POTENTIAL COMMON PATHWAY FOR ETHANOL-INDUCED IMMUNOMODULATION

被引:8
作者
BRAUN, KP
PEARCE, RB
PETERSON, CM
机构
[1] Sansum Medical Research Foundation, Santa Barbara, California
关键词
ACETALDEHYDE; ETHANOL; IL-2; IL-2R; CYTOKINE;
D O I
10.1111/j.1530-0277.1995.tb01513.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Variable immunobiological changes occur with alcohol consumption. Previous studies have shown that acetaldehyde forms stable adducts with serum proteins, including albumin. These adducts are elevated in persons and animals consuming ethanol. We examined the effect of serum protein-acetaldehyde adducts formed with fetal bovine serum (FBS) on concanavalin A-stimulated murine splenocytes. Interleukin-2 (IL-2) secretion and IL-2 receptor (IL-2R) expression were determined as a function of the effect of the acetaldehyde-protein adduct(s), FBS was incubated with acetaldehyde (500, 100, 50, 25, 10, and 0 mu M) for 1 hr at 37 degrees C. Excess acetaldehyde was removed by ultrafiltration using a 500 molecular weight cut-off membrane in 3 volumes. Free as well as bound acetaldehyde was quantified using fluorigenic HPLC before and after incubation. Recovered acetaldehyde correlated with the amount added (r(2) = 0.996). Splenocytes were cultured for 48 hr in complete medium containing 5% acetaldehyde-treated and 5% untreated FBS with 4 mu g/ml concanavalin A. Although cell viability was unchanged, acetaldehyde-treated FBS mixed with native FBS decreased IL-2 secretion in a dose-dependent manner. The percentage of cells expressing IL-2R was reduced only at the highest acetaldehyde-fas dose. Therefore, immunological effects ascribed to ethanol may result in part from the toxic properties of acetaldehyde-protein adducts on IL-2 secretion.
引用
收藏
页码:345 / 349
页数:5
相关论文
共 37 条
[21]   THE REACTION OF ACETALDEHYDE WITH BRAIN MICROTUBULAR PROTEINS - FORMATION OF STABLE ADDUCTS AND INHIBITION OF POLYMERIZATION [J].
MCKINNON, G ;
DEJERSEY, J ;
SHANLEY, B ;
WARD, L .
NEUROSCIENCE LETTERS, 1987, 79 (1-2) :163-168
[22]  
MESSNER RP, 1993, J LAB CLIN MED, V122, P506
[23]  
NAGUCHI M, 1993, CELL, V73, P147
[24]   IMPROVED METHOD FOR ACETALDEHYDE IN PLASMA AND HEMOGLOBIN-ASSOCIATED ACETALDEHYDE - RESULTS IN TEETOTALERS AND ALCOHOLICS REPORTING FOR TREATMENT [J].
PETERSON, CM ;
POLIZZI, CM .
ALCOHOL, 1987, 4 (06) :477-480
[25]  
SARAGOVI H, 1987, J IMMUNOL, V139, P1918
[26]  
SARAGOVI H, 1988, J IMMUNOL, V141, P476
[27]   ACETALDEHYDE BINDING INCREASES THE CATABOLISM OF RAT SERUM LOW-DENSITY LIPOPROTEINS [J].
SAVOLAINEN, MJ ;
BARAONA, E ;
LIEBER, CS .
LIFE SCIENCES, 1987, 40 (09) :841-846
[28]   ALCOHOLISM, INFECTION AND ALTERED HOST DEFENSES - REVIEW OF CLINICAL AND EXPERIMENTAL OBSERVATIONS [J].
SMITH, FE ;
PALMER, DL .
JOURNAL OF CHRONIC DISEASES, 1976, 29 (01) :35-49
[29]  
STEVENS VJ, 1981, J CLIN INVEST, V67, P362
[30]   THE GENERATION OF CYTOTOXIC LYMPHOCYTES-T AGAINST ACETALDEHYDE-MODIFIED SYNGENEIC CELLS [J].
TERABAYASHI, H ;
KOLBER, MA .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1990, 14 (06) :893-899